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ABSTRACT 
Aims: To investigate the impact of performing short bouts of seated upper body activity on 
postprandial blood glucose and insulin levels during prolonged sitting.  
Materials and methods:  Participants undertook two 7·5 hour experimental conditions in a 
randomised order: 1) prolonged sitting only 2) sitting interspersed with 5 minutes of seated 
arm ergometry every 30 minutes. Blood samples were obtained while fasting and 
throughout the postprandial period following ingestion of two standardised meals. 
Incremental Area Under the Curve (iAUC) was calculated for glucose and insulin throughout 
each experimental condition. Paired samples t-test assessed the difference in iAUC data 
between conditions for glucose (primary outcome) and insulin (secondary outcome).  
Results: Thirteen obese adults (7 female; 6 male; age: 66 ± 6 years, BMI: 33.8 ± 3.8 kg/m2 
(mean ± SD) completed this investigation. Compared with the prolonged sitting only 
condition, the implementation of seated arm ergometry every 30 minutes significantly 
reduced mean [95% CI] blood glucose iAUC (from 7.4 [5.2, 9.5] mmol·L-1·h to 3.1 [1.3, 5.0] 
mmol·L-1·h, p = 0.001). Significant reductions in mean insulin iAUC (from 696 [359, 1032] 
mU⋅L-1 ⋅h to 554 [298, 811] mU⋅L-1 ⋅h, p = 0.047) were also observed. 
Conclusion: Performing short bouts of arm ergometry during prolonged sitting attenuated 
postprandial glycaemia despite maintaining a seated posture. This may have clinical 
significance for those with weight bearing difficulty who may struggle with postural change. 
Trial registration: ClinicalTrials.gov (NCT02909894)  
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INTRODUCTION 
Greater time spent sedentary (defined as sitting or reclining with low energy expenditure 
(1)), is increasingly being recognised as an independent risk factor for morbidity 
(especially type 2 diabetes) (2-5) and mortality (2, 4-6), associations that persist after controlling 
for moderate-to-vigorous physical activity levels (2-5). However associations between 
sedentary behaviour and health may be attenuated when engaging in very high levels of 
physical activity (typically in the region of ≥ 60 min/day) (6).  
Epidemiological findings have been strengthened by recent experimental evidence showing 
beneficial effects of interrupting prolonged sitting on markers of metabolic health, 
particularly postprandial glycaemia. For example, interrupting sitting time with regular 
bouts of light intensity (7-10) and moderate intensity (8) (11-12) walking have shown to be 
effective at reducing postprandial blood glucose levels in overweight and obese adults (8), in 
those with dysglycaemia (7, 12), diagnosed type 2 diabetes (10), and in healthy, normal-weight 
populations (9, 11). Breaking up prolonged sitting time with standing (7) (13-14) or light resistance 
activities (10) (while in a standing posture), have also proven to be effective. 
Interrupting sitting time with upright (non-seated) activities therefore appears to be a viable 
way of attenuating postprandial glucose. Whether these improvements can be replicated by 
introducing upper body muscle activity while maintaining a seated posture is currently 
unknown. Addressing this question will help clarify whether it is the posture of sitting that is 
driving the association with poor health or whether it is the resulting generalised muscular 
inactivity. Importantly, investigating non-weight bearing strategies for reducing sedentary 
behaviour will also have important clinical implications for individuals who have restricted 
mobility or find standing difficult. In addition, strategies for breaking sedentary behaviour 
that have been investigated to date not only overlook those with weight bearing difficulty, 
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but have also been criticised for being disruptive and non-conducive to the working day (15). 
Given that seated strategies would not require vacating the desk area, this could pose as a 
more appealing option for sedentary workers. 
The aim of this study is to investigate whether performing short, frequent bouts of seated 
upper body activity (using similar energy expenditures to light intensity walking) can 
attenuate postprandial glycaemia.  
MATERIALS AND METHODS 
Trial design 
Each participant attended the research centre on three separate occasions between May 
and August 2016. The first visit involved consent, familiarisation and energy expenditure 
measurement. This was followed by two experimental condition visits that were at least 7 
days apart. A randomised cross-over design was used whereby each participant took part in 
two experimental treatment conditions in a random order, thereby acting as their own 
controls. Order randomisation was conducted by a statistician using an online tool. Due to 
the nature of the trial, participants were not blinded to their randomised order, however all 
outcomes including blood assays were analysed blinded to the experimental condition that 
they derived from. Prior to commencing, this study received ethical approval from the 
National Health Service (NHS) East Midlands - Leicester South Research Ethics Committee. 
This trial was registered with ClinicalTrials.gov (NCT02909894).  
Participants 
Fourteen obese adults (BMI ≥30kg/m2) deemed to be inactive (failing to meet physical 
activity guidelines for MVPA, defined as 150 minutes per week of self-reported moderate 
intensity physical activity or 75 minutes per week of self-reported vigorous intensity physical 
activity (16)) and at high-risk of type 2 diabetes according to the Leicester Practice Risk Score 
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(LPRS) (17) were identified and recruited from a database (18). The LPRS calculates risk of type 
2 diabetes based on six variables (age, sex, ethnicity, BMI, family history of the disease and 
antihypertensive drug usage), all individuals eligible for this study scored within the top 10% 
for risk within their family practice.  
Exclusion criteria were as follows; an inability to communicate in spoken English, diagnosed 
type 2 diabetes, cardiovascular disease, psychotic illness, pregnancy, steroid usage, regular 
smoking habit or an inability to walk without an assistive device. 
One individual was withdrawn due to having an HbA1c indicative of T2DM. This left thirteen 
participants who went on to complete the trial. This process is detailed in Figure 1. 
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Figure 1 – CONSORT diagram showing participant flow 
 
 
1 screen failure  
- Diagnosed with Type 2 Diabetes 
13 were order-randomised to the two repeated measure experimental conditions 
All 13 individuals completed both experimental conditions, 
providing a ‘complete case’ analysis.  
41 replies 
 
150 participants (identified through an internal database) were invited to participate in 
this study 
8 declined 
 
3 unable to contact 
 
3 reserves in case of 
drop-out 
 
 
13 individuals excluded following a pre-screening 
telephone conversation: 
 
- 7 reported engaging in regular structured 
exercise or having a B.M.I <30kg/m2 
- 3 reported being recently diagnosed with 
type 2 diabetes 
- 2 reported being unable to walk without 
an assistive device 
- 1 reported being a regular smoker 
 
14 provided consent and attended the familiarisation visit 
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Consent, familiarisation and energy expenditure (EE) assessment visit 
On arrival, a researcher described in detail all study procedures and written informed 
consent was obtained.  
As a part of the screening process, a venous blood sample was taken to assess glycated 
hemoglobin (HbA1c) levels, and confirm absence of type 2 diabetes (<6·5% 
[<47·5mmol/mol]) (19). Body weight (Tanita TBE 611: Tanita, West Drayton, U.K), waist 
circumference (midpoint between lower costal margin and iliac crest) and height were 
measured to the nearest 0·1kg, 0·5cm and 0·5cm, respectively. 
During this first visit, we also undertook arm ergometry EE testing. Specifically, we sought to 
identify the power output (watts) necessary to elicit the desired EE during the main 
experimental condition. To allow comparison of metabolic responses to arm ergometry with 
previous findings that have examined the impact of light walking (3 km/h) (7-10); we aimed to 
match participants’ arm ergometry EE to their 3 km/h walking EE. To achieve this, EE was 
captured: a) while at rest b) while walking at 3km/h and c) while performing arm ergometry 
at various power outputs. In order for EE to be derived throughout each of these three 
domains, participants wore a face mask that was directly attached to a breath-by-breath 
gas-analysis system (Metalyser 3B, Cortex Biophysik, Leipzig, Germany). Herein, oxygen 
uptake and carbon dioxide production were used to calculate EE via indirect calorimetry (20). 
Before undertaking each testing occasions (detailed below), the gas analyser was calibrated 
according to the manufacturer’s recommendations. 
In order to assess EE while at rest (phase a), each participant sat quietly (refraining from 
movement) for 30 minutes. Expired gas data was collected over the final 15 minutes of this 
30 minute period once values had stabilised. 
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In order to assess EE while walking at 3km/h (phase b), participants wore the face mask 
while walking on a motor driven treadmill (Technogym Excite® 700) for ten minutes. Expired 
gas data was collected in the latter 5 minutes.  
In order to assess EE during seated arm ergometry (phase c), participants wore the face 
mask while pedalling at various wattages on an arm ergometer (Monark Rehab Trainer 881 
E, HaB International Ltd, Warwickshire, UK). Participants performed three 5 minute bouts of 
arm ergometry, with the first bout standardised to a wattage of 15W for 5 min. For the 
remaining bouts, investigators manipulated the resistance of the arm ergometer and/or the 
speed at which the participants pedalled until the wattage of arm ergometry initiated an EE 
that matched that of light walking (this ranged from 15 - 35W). Expired gas data was 
collected in the 2nd 3rd and 4th minute, discarding both the first and last minute from each 
bout. The face-mask was removed for 5minutes in between each bout in order for EE 
outputs to return to their resting level prior to the next measurement. From these three 
bouts, the wattage of arm ergometry that most closely resembled the average EE of light 
walking was prescribed in the subsequent experimental condition.  
Finally, participants were issued a GENEActiv accelerometer (ActivInsights Ltd, 
Cambridgeshire, UK) to wear on their non-dominant wrist for 24 hours/day for 7 
consecutive days, allowing quantification of habitual physical activity and sedentary 
behaviour levels. 
Experimental procedure 
Participants were asked to avoid alcohol and caffeine for 48 hours preceding experimental 
conditions and to replicate their diet in the 24 hours before main trials. Given that the 
influence of an acute bout of physical activity on insulin sensitivity can persist for 48 hours 
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(21), avoidance of moderate and vigorous physical activity (MVPA) for this timeframe was 
also instructed. GENEActiv accelerometers were worn in the 2 days leading up to each 
experimental condition to confirm compliance with the exercise restriction. Participant’s 
fasted from 10pm on the evening before main trials with only water permitted to drink.  
The two experimental treatment conditions that formed this repeated measures crossover 
trial were as follows:  
1) Prolonged sitting only - participants sat in a designated room for 7.5 hours (occupied with 
a desk, books, and laptop with internet services) while minimising excessive movements. 
Lavatory breaks were permitted using a wheelchair to and from the lavatory to further 
reduce unnecessary movements that could confound the study. 
2) Arm ergometry breaks - participants emulated the 7.5 hour prolonged sitting condition, 
but every 30 minutes they performed 5 minutes of arm ergometry. These bouts were 
performed 12 times, totalling one hour of seated upper body activity and 6·5 hours of 
sedentary time throughout the course of the experimental day. As mentioned previously, 
the intensity of arm ergometry performed was dictated by phase b) and c) of the EE testing 
performed during visit one. The selected arm ergometry intensities closely resembled the EE 
achieved during that of the 3km/h light intensity walk for each participant.  
On arrival at the research centre, participants had a cannula fitted into an accessible vein 
from which 10mL samples were obtained throughout the day. Immediately following the 
two fasting samples (depicted at time points -1 and 0 in Figure 2), participants were given a 
standardised breakfast meal consisting of 8kcal per kilogram of body weight, with a 
macronutrient composition reflective of co-ingestion in modern western diets (14% protein, 
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51% carbohydrate and 35% fat). Once breakfast had been consumed (within ≤15minutes), 
blood sampling commenced at 30, 60, 120, and 180 minutes thereafter, enabling us to 
capture the postprandial period. An identical lunch meal was then issued (time point 3 in 
Figure 2) and sampling continued in the same fashion at 30, 60, 120 and 180 minutes 
afterward. Participants were supervised by study staff to ensure compliance with the 
protocol and were asked to wear an activPAL monitor to objectively confirm sitting time 
during both experimental conditions. Ad libitum water consumption was made consistent 
between conditions. 
Measuring mood during experimental conditions 
The Feeling Scale (22) was used to quantify mood/affect prior to each blood sample (10 times 
in total) for both experimental conditions. Participants were asked to estimate their current 
mood state on an 11-point scale (very good= +5, 0 = neutral and very bad= –5) throughout 
the day.  
Safety 
Incidences of hypoglycaemia (defined as glucose levels below 4 mmol/L) during the final 
measurement period before lunch (3 hours post breakfast) and in the final measurement 
period of the day (3 hours post lunch) were also investigated during each experimental 
condition. 
 
Free-living activity monitor processing 
ActivPAL proprietary software (activPAL Professional V5.9.1.1) was used to create processed 
csv event files in order to quantify postural data collected during the 7.5 hour experimental 
conditions. GENEActiv .bin files were analysed with R-package GGIR version 1.2- 11 
(http://cran.r-project.org) (23 – 24). Habitual data were included if participants had over 16 
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hours of wear-time recorded during the 24 hour day of interest, and if they had more than 3 
valid days of data collected. Moderate to vigorous physical activity was calculated using an 
acceleration threshold of 100 mg (25). MVPA bouts were identified as ≥ 10 min of 
consecutive 5 second epochs where 80% of epochs were equal to, or higher than, the 
100mg threshold. Time spent in 0- 50mg and 50 – 100mg was used to establish sedentary 
(minus sleep time) and light activity, respectively.  
A summary of all GENEActiv data collected at each phase of the study is detailed in 
Supplementary Table 1. ActivPAL data collected during experimental conditions is detailed 
in Supplementary Table 2. 
Biochemical analysis 
Glucose (primary outcome measure) was analysed on the day of collection by the University 
Hospitals of Leicester pathology department using standard quality controlled enzymatic 
assays with commercially available kits (Beckman, High Wycombe, U.K).  
Centrifugated plasma samples (spun at 3,000g for 10 minutes immediately following 
extraction) were stored in -80·C freezers. Insulin (secondary outcome measure) was 
analysed from these collectively at the end of the trial using an electrochemiluminescence 
assay (Meso Scale Discovery). Each sample was ran in duplicate to ensure reliability of 
readings. Duplicate sample values with ≥20% variability were reanalysed. Ambient 
conditions of the laboratory were kept consistent. 
Sample size 
The primary aim of this study was to assess the difference in postprandial glucose levels 
between the two experimental treatment conditions. Assuming a population standard 
deviation of 2.5 mmol·L-1·h in glucose iAUC and a within-person correlation of 0.5, 13 
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participants were required to complete the study in order to detect a difference of 
1.8mmol·L-1·h in blood glucose iAUC between the experimental conditions with 90% power 
(alpha=0.05).  
Statistical analysis 
Missing glucose and insulin data during the experimental conditions (highlighted in 
Supplementary Table 3) resulted from an inability to draw enough blood from the cannula 
at given time points and accounted for roughly 3.7% of required samples (19 out of 520). 
These 19 missing data points were imputed via a regression model used previously (7). The 
iAUC of glucose and insulin was calculated for each experimental condition. Total AUC was 
calculated by applying the trapezium rule. Subtraction of the fasting area from this total 
then gave a single value representing incremental AUC for each participant. Utilising iAUC as 
opposed to total AUC is common practice in acute interventions where fasting levels should 
be unaffected by the intervention (26). Each outcome (glucose and insulin iAUC) was 
compared between treatments using a paired samples t-test. Data from the feeling scale 
were averaged across each condition and analysed using a paired t-test.  All statistical 
analyses were performed using IBM SPSS Statistics (Version 22·0) and statistical significance 
was set to p < 0·05 throughout. Data distribution was interpreted by visual inspection and 
through the Shapiro-Wilk test. Normally distributed descriptive data and experimental data 
are presented as Mean ± SD and Mean (95% CI), respectively, while all non-parametric data 
is reported as Median (IQR) unless specified otherwise. For the experimental data, the 
unstandardized residuals were checked for normality. 
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RESULTS  
Descriptive characteristics of those who completed this study are summarised in Table 1 (n 
=13). The study characteristics show that the energy expenditure of arm ergometry breaks 
conducted in the experimental condition was similar to that achieved through a light 
intensity walk at 3km/h (4.5 vs 4.6 kcal/min, respectively), however the average Respiratory 
Exchange Ratio (RER) was higher during arm ergometry compared to light intensity walking 
(1.00 vs 0.84, p < 0.001).  
Experimental data 
Biochemical results collected during each experimental condition are presented in Figure 2. 
The mean (95% CI) glucose iAUC response during the arm ergometry breaks condition (3.1 
[1.3, 5.0] mmol·L-1·h) was significantly lower than the mean glucose iAUC response to the 
prolonged sitting only condition (7.4 [5.2, 9.5] mmol·L-1·h), p = 0.001. This was also the case 
for mean insulin iAUC (554 [298, 811] mU⋅L-1⋅h vs 696 [359, 1032] mU⋅L-1⋅h, p = 0.047). 
Physical activity and sedentary time data 
Physical activity and sedentary behaviour data is displayed in Supplementary Table 1. Free-
living accelerometer data collected after the familiarisation visit (n = 13), showed that 
participants spent on average 644 ± 106 min/day sedentary and only engaged in 2 [0, 13] 
min/day of purposeful MVPA, thus confirming the inactive nature of this study cohort.  
MVPA data collected in the two days leading up to the prolonged sitting only condition          
(0 [0, 10] min/day) and in the two days leading up to the arm ergometry breaks condition   
(0 [0, 7] min/day) confirm adherence to the standardised exercise restriction. 
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Mood, tolerance and safety 
Mean ± SD self-reported feelings throughout the day were 3.1 ± 1.1 and 2.7 ± 1.2 for the 
prolonged sitting only and arm ergometry breaks conditions, respectively (p = 0.101 for 
difference), demonstrating positive mood states during both conditions. All participants 
completed the required number of arm ergometry bouts, and none reported 
musculoskeletal pain or discomfort.  
Two participants did have asymptomatic hypoglycaemia during the final measurement of 
the day during the arm-ergometry breaks condition with no incidences reported during the 
prolonged sitting condition.  
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Table 1: Metabolic, demographic, and anthropometric characteristics taken at 
familiarisation alongside important in-study characteristics 
 
Characteristics Overall 
(n = 13) 
Age (years) 66 ± 6 
Female 7 [54] 
BMI (kg/ m2) 33.8 ± 3.8 
Body weight (kg) 93.2 ± 13.2 
Waist circumference (cm) 105 ± 16 
HbA1c (%) 5.5 ± 0.4 
HbA1c (mmol/mol) 37 ± 4 
Total cholesterol (mmol/L) 4.6 ± 0.6 
Resting heart rate (bpm) 60 ± 6 
Systolic blood pressure (mm Hg) 140 ± 13 
Diastolic blood pressure (mm Hg) 79 ± 9 
White European 13[100] 
Experimental characteristics  
Energy intake per experimental meal (kcal/meal) 
 
746 ± 106 
Prescribed power output of arm ergometry (Av.Watts) 
 
20 ± 4 
Energy expenditure while walking at 3km/h 
(Av.kcal/min) 
 
4.6 ± 1.0 
Energy expenditure at prescribed wattage of arm 
ergometry (Av.kcal/min) 
 
4.5 ± 0.9 
Av. Respiratory Exchange Ratio while walking at 
3km/h (VCO2/VO2) 
 
0.84 ± 0.07 
Av. Respiratory Exchange Ratio at prescribed power 
output of arm ergometry (VCO2/VO2) 
 
1.00 ± 0.07 
Data are presented as Mean ± SD or n [%] 
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 Figure 2 – Analyte AUC data between experimental conditions 
P = 0.001 
P = 0.047 
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DISCUSSION 
This study is the first to investigate the metabolic impact of interrupting postprandial 
prolonged sitting time with regular bouts of upper body activity while remaining seated. Our 
results show that introducing 5 minutes of arm ergometry every 30 minutes while remaining 
in a seated posture is well tolerated and can attenuate postprandial blood glucose and 
insulin levels by approximately 57% and 20% respectively compared to that of prolonged 
sitting only. The fact that the observed reductions in glucose coincided with reductions in 
insulin concentration is suggestive of improved insulin sensitivity during the seated activity 
breaks condition using upper body muscle activation. 
Our findings are consistent with the majority of experimental research to date. For example, 
experimental studies that have interrupted prolonged sitting with 3km/h walking breaks 
have led to clinically significant reductions in postprandial blood glucose by 28% (7) when 
implemented for 5 minutes every 30 minutes; by 39% when implemented for 3 minutes 
every 30 minutes (10) and by 16% (9) to 24% (8) when implemented for 2 minutes every 20 
minutes post-meal. Our findings add to this evidence by demonstrating that regular bouts of 
seated arm ergometry may also be a viable method of improving postprandial glycaemia. 
Moreover, despite closely matching the energy demand of arm ergometry breaks to that of 
the 3km/hr walking bouts used in previous studies, we achieved a larger reduction in 
postprandial glucose iAUC than observed in these studies, even compared to those 
operating activity breaks at the same time intervals (7).  
Given that arm ergometry breaks were implemented while maintaining a seated posture, 
our findings could not have been driven by postural change, and benefits to postprandial 
glycaemia may be attributed to other factors. For instance, physical activity breaks are 
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accompanied by increases in muscle activation. These increases in muscle activation not 
only raise energy expenditure but also increase blood flow and upregulate GLUT-4 
expression in a dose dependant manner, which helps to restore homeostasis of postprandial 
glycaemia (27-28). Greater intensity of muscle activation in the smaller muscle mass during 
arm ergometry may have been necessary to achieve the same energy expenditure elicited 
by a 3km/hr walk. In turn, this greater muscle activation may have compensated for the 
limited muscle mass involved, and may explain the enhanced blood glucose utilisation 
observed here. This was supported in the present study by the higher RER observed during 
the arm ergometry compared to the energy matched walking, suggesting a greater relative 
intensity.  Previous research has shown that enhanced postprandial blood glucose 
regulation is observed following higher intensity physical activity bouts compared to energy 
matched lower intensity physical activity bouts (29-31). Thus, the higher intensity of arm 
ergometry, compared to light walking, may have helped augment reductions in postprandial 
glucose. Further research is therefore needed to assess whether reductions in postprandial 
glucose are also observed when using arm ergometry at a perceived light intensity. 
The current study suggests an alternative strategy to help regulate postprandial glycaemia 
while sitting in a population at high risk of type 2 diabetes. Not only are arm ergometry 
breaks an alternative strategy, but they may even act as a sole strategy for individuals with 
weight bearing difficulty such as wheelchair users and those with severe peripheral 
neuropathy, which is thought to affect up to half of all people diagnosed with T2DM (32). 
Given the disruptive nature of alternative strategies such as frequent walking breaks, seated 
activity may also appeal to office workers who find it difficult to leave their desk or office 
space at regular intervals throughout the day. Portable lightweight desktop arm ergometers 
19 
 
may also be of use in a hospital environment to improve postprandial glycaemia of patients 
who are bed bound yet able to sit upright.  
The main strength of this study lays in the exploration of a novel strategy to alleviate the 
deleterious impacts of prolonged sitting bouts on postprandial glycaemia in a population at 
high risk of developing type 2 diabetes recruited through a primary care setting. However, it 
is important to acknowledgement some limitations.  
Although comparing our findings to those observed when introducing 3km/hr walking 
breaks (7-10), we did not include a third experimental walking condition which may have 
strengthened our conclusions. In addition, this study was not designed to elucidate potential 
mechanisms underpinning the acute reductions in postprandial glucose and insulin 
concentrations observed when employing seated activity breaks. However, this study was 
specifically designed to establish proof-of-concept for the efficacy of employing seated arm 
ergometry breaks as a method of acutely reducing postprandial glucose concentrations 
during prolonged sedentary behaviour. This is clinically important given that exaggerated 
postprandial glucose oscillations are associated with the development of type 2 diabetes (33), 
cardiovascular disease (33-35) and obesity (33). Even small elevations in postprandial glycaemia 
are thought to contribute to the development of atherosclerosis and subsequent coronary 
heart disease events (36). 
While a sample size of 13 provided adequate power for comparison between experimental 
conditions, the small sample makes it harder to generalise findings beyond the specific 
subject population recruited to this study. Given that efforts to manipulate blood glucose 
control are thought to be more pronounced in those with worse glycaemia (37), the potential 
of such interventions in a diagnosed type 2 diabetes population would also be intriguing and 
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warrants further investigation. Future intervention studies observing the impacts of seated 
activity breaks using more ecologically valid regimes in settings outside of the laboratory 
(such as the home, or in a hospital environment) would also be of interest. The ability to 
emulate reductions in postprandial glycaemia through regular bouts of electro-stimulated 
muscular contractions would also be an interesting focal point for future research given 
recent links to improved insulin sensitivity (38) and its potential application to non-weight 
bearing populations. Likewise, given that arm ergometers are not easily accessible to all, 
engaging in seated upper body resistance band exercises could also pose as an intriguing 
alternative for future research. Future research exploring the minimal time, frequency and 
intensity that activity breaks can be implemented to bring about clinically significant 
improvements in postprandial glycaemia is warranted to promote more attractive, feasible 
and sustainable strategies. In addition, given that two subjects were found to be over the 
threshold for asymptomatic hypoglycaemia at the end of the arm ergometer condition, the 
safety of the current regime needs further investigation in those with a high risk or 
diagnosed T2DM, particularly in the 24 hours following the intervention. Further research 
utilising hyperinsulinaemic-euglycaemic clamp techniques could also be used to give more 
detailed insight into the dynamics of glucose metabolism when employing seated upper 
body breaks during prolonged sedentary behaviour.  
In conclusion, this study demonstrates that seated arm ergometry breaks are a viable way to 
attenuate postprandial glycaemia. This suggests that breaking up the posture of sitting may 
not be necessary to elicit glycaemic benefit and that interventions to reduce sedentary 
behaviour should not focus solely on postural change. 
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